Oakstone The Brigham Innovations and New Practices in Internal Medicine 2026

The Brigham Internal Medicine 2026 | Harvard Medical School Faculty, Cardiology, Diabetes, Obesity, Infectious Diseases, Gastroenterology, Nephrology, Pulmonology, Geriatrics, AI & Clinical Practice Updates

The Oakstone The Brigham Innovations and New Practices in Internal Medicine 2026 provides a comprehensive, evidence-based educational update on emerging clinical developments, new treatment strategies, diagnostic advances, and evolving practice guidelines across the major specialties of internal medicine.

Produced by Oakstone Publishing (CMEinfo) with educational content from Brigham and Women’s Hospital, this program brings together expert Harvard Medical School faculty to examine important innovations affecting everyday clinical practice.

Originally released on August 31, 2026, this educational video program addresses recent advances in cardiovascular medicine, diabetes, obesity, infectious diseases, gastroenterology, hepatology, nephrology, pulmonary medicine, rheumatology, geriatrics, neurology, women’s health, preventive medicine, and primary care.

The Brigham Innovations and New Practices in Internal Medicine 2026 curriculum emphasizes practical application of current evidence, diagnostic reasoning, individualized treatments, and evidence-based clinical decision-making.

The program also examines rapidly developing areas of contemporary medicine, including artificial intelligence and ChatGPT, longevity science, emerging obesity medications, diabetes technology, health equity, cannabinoid medicine, opioid use disorder, HIV prevention, and new cardiovascular therapies.

Rather than focusing exclusively on traditional disease reviews, the program explores what has changed in internal medicine and how these developments can be incorporated into patient care.

Clinical presentations and case-based discussions help clinicians evaluate new evidence, understand evolving medical recommendations, and integrate contemporary treatment options into practice.

Course Details

• Course: Oakstone The Brigham Innovations and New Practices in Internal Medicine 2026
• Official Program: The Brigham Internal Medicine: Innovations and New Practices
• Content Institution: Brigham and Women’s Hospital
• Academic Affiliation: Harvard Medical School
• Publisher: Oakstone Publishing / CMEinfo
• Original Live Course: May 11–15, 2026
• Original Video Release: August 31, 2026
• Original CME Credit Expiration: August 30, 2029
• Format: Online Video Educational Program
• Primary Specialty: Internal Medicine
• Additional Focus: Hospital Medicine, Primary Care, Cardiology, Endocrinology, Gastroenterology, Nephrology, Pulmonology, Neurology, Infectious Diseases, Rheumatology, Geriatrics and Women’s Health
• Language: English
• Course Directors: Ole-Petter R. Hamnvik, MB BCh BAO, MMSc, and Colleen A. Monaghan, MD
• Official AMA CME: Up to 33.5 AMA PRA Category 1 Credits™
• Official ABIM MOC: Up to 33.5 Points
• Educational Approach: Expert Video Lectures, Clinical Cases, Evidence-Based Reviews and Practice-Focused Updates

The original Oakstone course provides CME and MOC credit opportunities to eligible registered participants who complete the required evaluation and post-test.

Publisher credit, official course registration, and online platform access are not included with separately distributed MedicalAmboss educational files.

Target Audience

The program is designed for healthcare professionals seeking practical updates on contemporary internal medicine.

The target audience includes:

• Internal Medicine Physicians
• General Internists
• Hospitalists
• Primary Care Physicians
• Family Medicine Physicians
• General Practitioners
• Cardiologists
• Endocrinologists
• Gastroenterologists
• Nephrologists
• Pulmonologists
• Infectious Disease Physicians
• Geriatricians
• Rheumatologists
• Neurologists
• Advanced Practice Providers
• Physician Assistants
• Nurse Practitioners
• Medical Residents
• Clinical Fellows
• Other Healthcare Professionals Involved in Adult Medical Care

The program is particularly useful for clinicians who wish to understand important changes in disease management, diagnostic testing, preventive care, and therapeutic approaches.

Program Overview

Internal medicine continues to evolve as new clinical evidence, medical technologies, treatments, and guidelines influence healthcare delivery.

Physicians must interpret these developments while managing patients with complex medical conditions, multimorbidity, and competing treatment priorities.

The Brigham Internal Medicine 2026 program addresses these challenges through an extensive review of recent innovations and their practical implications.

The curriculum covers:

• Heart Failure Treatment
• Atrial Fibrillation
• Valvular Heart Disease
• Cardiovascular Risk Reduction
• Lipid-Lowering Therapy
• Anticoagulation
• Hypertension
• Diabetes Technology
• Diabetes Treatment Guidelines
• Obesity Medications
• Dietary Obesity Management
• Primary Aldosteronism
• Thyroid Disorders in Pregnancy
• Bone Health
• Metabolic Dysfunction-Associated Steatotic Liver Disease
• GERD and Barrett’s Esophagus
• Helicobacter pylori
• Irritable Bowel Syndrome
• Chronic Kidney Disease
• Antimicrobial Stewardship
• Vaccinations
• Sexually Transmitted Infections
• HIV Prevention
• Doxy-PEP
• Asthma
• COPD
• Headache Disorders
• Stroke Management
• Dementia and Alzheimer’s Disease
• Longevity Science
• Geriatric Medicine
• Rheumatology
• Gout and Crystal Deposition Disease
• Menopause Management
• Gynecologic Cancer Screening
• Pelvic Floor Disorders
• Cancer Screening
• Dermatology
• Depression and Anxiety
• Opioid Use Disorder
• Artificial Intelligence in Medicine
• Health Equity
• Exercise and Preventive Medicine

The program emphasizes translating recent clinical developments into patient-centered, evidence-based practice.

Learning Objectives

After completing the original educational program, participants should be better able to:

1. Interpret current evidence and emerging clinical developments relevant to internal medicine practice.
2. Apply current clinical guidelines and evidence-based recommendations to the evaluation and management of common and complex medical conditions.
3. Apply updated diagnostic and clinical reasoning strategies to evaluate challenging patient presentations.
4. Integrate contemporary pharmacologic, procedural, technological, and nonpharmacologic treatments into individualized management plans.
5. Deliver equitable, inclusive, and patient-centered care that considers race, ethnicity, sex, gender identity, sexual orientation, disability status, and other individual patient factors.

Complete 2026 Course Curriculum

The following lectures and faculty are organized by clinical specialty for easier review. This organization is based on the supplied course curriculum rather than a claim that the recordings are arranged in this exact sequence.

Session I – Cardiology and Cardiovascular Medicine

Treatment of Heart Failure in 2026

Faculty: Anju Nohria, MD, MSc

Reviews contemporary developments in heart failure diagnosis and treatment.

Important clinical considerations include:

• Heart Failure Classification
• Heart Failure With Reduced Ejection Fraction
• Heart Failure With Preserved Ejection Fraction
• Guideline-Directed Medical Therapy
• SGLT2 Inhibitors
• Volume Management
• Risk Stratification
• New Treatment Strategies

Atrial Fibrillation

Faculty: Paul C. Zei, MD, PhD, FHRS, FACC

Examines current approaches to atrial fibrillation management.

Important topics include:

• Atrial Fibrillation Diagnosis
• Rate Control
• Rhythm Control
• Stroke Prevention
• Anticoagulation
• Catheter Ablation
• Patient Risk Assessment
• Individualized Treatment Selection

Percutaneous Approaches to Valvular Disease

Faculty: Pinak B. Shah, MD

Reviews advances in catheter-based treatment of valvular heart disease.

Relevant areas include:

• Aortic Valve Disease
• Mitral Valve Disease
• Transcatheter Valve Interventions
• Patient Selection
• Structural Heart Disease
• Procedural Risk
• Multidisciplinary Valve Care

Recent Advances in Lipid Therapy and Cardiovascular Risk Reduction

Faculty: Pradeep Natarajan, MD, MMSc

Examines contemporary approaches to lipid management and cardiovascular prevention.

Important considerations include:

• LDL Cholesterol Reduction
• Atherosclerotic Cardiovascular Disease
• Risk Stratification
• Statin Therapy
• Non-Statin Lipid Treatments
• Emerging Lipid-Lowering Agents
• Cardiovascular Prevention

Thrombosis and Anticoagulation

Faculty: Gregory Piazza, MD, MS

Reviews developments in thrombotic disease and anticoagulant therapy.

Topics include:

• Venous Thromboembolism
• Deep Vein Thrombosis
• Pulmonary Embolism
• Direct Oral Anticoagulants
• Bleeding Risk
• Anticoagulation Management
• Treatment Duration

Best Practices in Hypertension Management

Faculty: Romela Petrosyan, MD, SM, FASN, FACP

Examines evidence-based approaches to hypertension.

Important areas include:

• Blood Pressure Assessment
• Cardiovascular Risk
• Hypertension Guidelines
• Pharmacological Treatment
• Resistant Hypertension
• Secondary Hypertension
• Individualized Treatment Goals

Aging and the Cardiovascular System

Faculty: Ami Bhatt, MD

Reviews cardiovascular changes associated with aging.

Important considerations include:

• Cardiovascular Aging
• Vascular Function
• Cardiac Structure
• Age-Related Cardiovascular Risk
• Functional Assessment
• Preventive Strategies
• Clinical Management

Session II – Diabetes, Endocrinology and Obesity Medicine

Thyroid Disease in Pregnancy

Faculty: Athanasios Bikas, MD, PhD

Examines thyroid disorders during pregnancy, including diagnostic assessment, maternal-fetal considerations, and treatment planning.

Advances in Diabetes Technology

Faculty: Nadine E. Palermo, DO

Reviews developments in continuous glucose monitoring, insulin delivery technologies, and technology-supported diabetes management.

Bone Health in 2026

Faculty: Sharon H. Chou, MD

Examines osteoporosis, bone health assessment, fracture prevention, and evolving treatment strategies.

Diabetes Management – New Drugs, Approaches, and Guidelines

Faculty: Marie E. McDonnell, MD

Reviews contemporary diabetes medications, treatment guidelines, cardiovascular and renal considerations, and individualized glycemic management.

Dietary Approaches to Obesity Management

Faculty: Chika V. Anekwe, MD, MPH

Explores dietary interventions, nutritional planning, weight management, and evidence-based lifestyle strategies for obesity treatment.

Primary Aldosteronism

Faculty: Anand Vaidya, MD, MMSc

Reviews recognition, screening, diagnosis, and treatment considerations for primary aldosteronism as a cause of secondary hypertension.

What’s New in Obesity Medications, Devices, and Procedures

Faculty: Priya Jaisinghani, MD, DABOM

Examines newer pharmacologic, device-based, and procedural approaches to obesity management.

Topics of clinical relevance include:

• Anti-Obesity Medications
• Incretin-Based Therapies
• GLP-1 Receptor Agonists
• Patient Selection
• Treatment Safety
• Weight-Loss Outcomes
• Obesity Procedures
• Long-Term Weight Management

Session III – Gastroenterology and Hepatology

Update in MASLD

Faculty: M. Valerie Lin, MD

Reviews metabolic dysfunction-associated steatotic liver disease, including risk assessment, noninvasive evaluation, metabolic risk factors, and treatment considerations.

Updates in Upper Gastrointestinal Disorders: GERD, Barrett’s Esophagus, and H. pylori

Faculty: Molly L. Perencevich, MD

Examines updated approaches to upper gastrointestinal conditions.

Important topics include:

• Gastroesophageal Reflux Disease
• Barrett’s Esophagus
• Helicobacter pylori
• Diagnostic Testing
• Medical Management
• Surveillance
• Treatment Selection

What’s New in Irritable Bowel Syndrome

Faculty: Kyle D. Staller, MD, MPH

Reviews current developments in irritable bowel syndrome diagnosis and treatment, including symptom-based evaluation, therapeutic selection, dietary considerations, and patient-centered management.

Session IV – Infectious Diseases

Hot Topics in Infectious Diseases

Faculty: Sarah P. Hammond, MD

Examines emerging infectious disease developments and clinically important updates relevant to internal medicine.

Responsible Use of Antibiotics

Faculty: Paul E. Sax, MD

Reviews antimicrobial stewardship and appropriate antibiotic prescribing.

Topics include:

• Antibiotic Selection
• Antimicrobial Resistance
• Diagnostic Stewardship
• Avoiding Unnecessary Treatment
• Treatment Duration
• Patient Safety

Update on Immunizations

Faculty: Daniel A. Solomon, MD, FIDSA

Reviews current vaccination strategies, immunization recommendations, adult preventive care, and special population considerations.

Update on STIs, PrEP, and Doxy PEP

Faculty: Kevin L. Ard, MD, MPH

Examines contemporary approaches to sexually transmitted infection prevention and management.

Important topics include:

• STI Screening
• HIV Prevention
• Pre-Exposure Prophylaxis
• Doxycycline Post-Exposure Prophylaxis
• Risk Assessment
• Preventive Counseling
• Evidence-Based Recommendations

Session V – Nephrology

What’s New, Innovative, and Controversial in Chronic Kidney Disease

Faculty: J. Kevin Tucker, MD

Reviews emerging evidence and current clinical controversies in chronic kidney disease management.

Important considerations include:

• Chronic Kidney Disease
• Kidney Function Assessment
• Albuminuria
• Cardiovascular Risk
• Renal-Protective Treatments
• CKD Progression
• Treatment Guidelines
• Individualized Patient Management

Session VI – Geriatric Medicine, Aging and Longevity

Longevity Overview

Faculty: Julia V. Loewenthal, MD

Introduces important concepts in longevity medicine, healthy aging, and the interpretation of emerging evidence related to aging interventions.

Longevity Keynote – Aging and Longevity for the Internist: Why and Why Now?

Faculty: Louise Aronson, MD, MFA

Explores the relevance of longevity science and aging-related healthcare to contemporary internal medicine.

Aging Biomarkers

Faculty: Lewis A. Lipsitz, MD

Examines biological markers associated with aging, their potential applications, and limitations in clinical interpretation.

Longevity Cases

Faculty:

• Julia V. Loewenthal, MD
• Jay R. Luthar, MD, DipABLM

Uses clinical cases to examine practical considerations in longevity medicine and healthy aging.

Update in Geriatrics – The Latest Studies and Their Clinical Relevance

Faculty: Suzanne E. Salamon, MD

Reviews important recent geriatric medicine research and its implications for the care of older adults.

Update in Dementia and Alzheimer’s Disease

Faculty: Gad A. Marshall, MD

Examines developments in dementia diagnosis, cognitive assessment, Alzheimer’s disease, disease-modifying treatments, and patient management.

Session VII – Rheumatology

Update in Rheumatology

Faculty: Eli M. Miloslavsky, MD

Reviews important developments in inflammatory and autoimmune rheumatological disorders.

Topics may inform clinical evaluation, diagnosis, treatment selection, and ongoing disease monitoring.

Advances in Gout and Crystal Deposition Disease

Faculty: Sara K. Tedeschi, MD, MPH

Examines recent developments in gout and related crystal deposition diseases.

Important considerations include:

• Gout
• Hyperuricemia
• Crystal Arthritis
• Urate-Lowering Therapy
• Acute Flare Management
• Diagnostic Evaluation
• Long-Term Disease Control

Session VIII – Pulmonary Medicine

Asthma Update

Faculty: Elliot Israel, MD, MSc (Hon)

Reviews developments in asthma diagnosis, treatment selection, inhaled therapies, biologic treatment considerations, and individualized disease management.

Update in COPD

Faculty: Craig P. Hersh, MD, MPH

Examines contemporary chronic obstructive pulmonary disease management.

Important topics include:

• COPD Assessment
• Exacerbation Risk
• Bronchodilator Therapy
• Inhaled Treatments
• Preventive Care
• Smoking Cessation
• Long-Term Management

Session IX – Neurology

Advances in Diagnosis and Management of Headache

Faculty: Carolyn A. Bernstein, MD, FAHS

Reviews advances in headache assessment and treatment, including migraine evaluation, preventive therapies, and individualized treatment strategies.

Stroke Management in 2026

Faculty: Alexis T. Roy, MD, MSc

Examines contemporary approaches to stroke assessment, treatment, secondary prevention, and multidisciplinary management.

Session X – Women’s Health

Pelvic Floor Disorders – Medical Management and More

Faculty: Neeraj Kohli, MD, MBA

Reviews pelvic floor dysfunction, urinary symptoms, clinical evaluation, conservative management, and treatment considerations.

Gynecologic Cancer Screening

Faculty: Colleen M. Feltmate, MD

Examines current screening approaches, cancer risk assessment, preventive strategies, and appropriate referral considerations.

Update in Menopause Management

Faculty: Deborah Gomez Kwolek, MD, FACP, MSCP, FAMWA

Reviews clinical developments in menopause management.

Important topics include:

• Menopausal Symptoms
• Hormonal Therapy
• Non-Hormonal Treatment
• Treatment Safety
• Long-Term Women’s Health
• Individualized Clinical Decisions

Session XI – Primary Care and General Internal Medicine

Clinical Cases in Dermatology

Faculty: Adam D. Lipworth, MD

Reviews common and challenging dermatological presentations through clinical cases, emphasizing recognition, differential diagnosis, and appropriate management.

Cancer Screening Cases

Faculty: Leigh H. Simmons, MD

Examines practical cancer screening decisions using case-based examples.

Important considerations include screening eligibility, risk assessment, preventive counseling, and interpretation of recommendations.

Depression and Anxiety

Faculty: David S. Kroll, MD

Reviews assessment and treatment of depression and anxiety in medical practice.

Topics include diagnostic evaluation, pharmacological therapy, nonpharmacological approaches, and longitudinal care.

Best Practices for Preoperative Evaluation

Faculty: Adam C. Schaffer, MD, MPH

Examines evidence-based preoperative assessment and optimization.

Important considerations include:

• Perioperative Risk
• Cardiovascular Evaluation
• Medication Management
• Comorbid Conditions
• Surgical Preparation
• Appropriate Testing

Exercise for Health – What’s New in 2026

Faculty: Meagan M. Wasfy, MD, MPH

Reviews the role of physical activity in health promotion, cardiovascular prevention, chronic disease management, and personalized exercise recommendations.

Session XII – Emerging and Innovative Areas of Medicine

Innovations in Cannabinoid Medicine

Faculty: Jordan Tishler, MD

Examines contemporary evidence, clinical controversies, potential therapeutic applications, and safety considerations involving cannabinoid medicine.

Advancing Patient Equity in Medicine

Faculty: Bram P. Wispelwey, MD, MS, MPH

Reviews approaches to improving equity in healthcare.

Important themes include:

• Healthcare Disparities
• Access to Care
• Inclusive Clinical Practice
• Social Determinants of Health
• Patient-Centered Care
• Quality Improvement

AI and ChatGPT

Faculty: Rebecca G. Mishuris, MD, MS, MPH, FAMIA

Explores the use of artificial intelligence and generative AI in clinical medicine.

Important considerations include:

• Clinical Decision Support
• Generative Artificial Intelligence
• Documentation
• Healthcare Workflows
• AI Reliability
• Patient Safety
• Bias
• Human Oversight
• Appropriate Clinical Applications

Management of Opioid Use Disorder

Faculty: Joji Suzuki, MD

Reviews evidence-based approaches to opioid use disorder, including clinical assessment, medication treatment, harm reduction, relapse prevention, and coordinated care.

Major Topics Covered

• The Brigham Internal Medicine 2026
• Innovations and New Practices in Internal Medicine
• Harvard Medical School Faculty
• Evidence-Based Internal Medicine
• Clinical Practice Updates
• Heart Failure
• Atrial Fibrillation
• Valvular Heart Disease
• Lipid Management
• Cardiovascular Risk Reduction
• Thrombosis
• Anticoagulation
• Hypertension
• Diabetes Technology
• Continuous Glucose Monitoring
• Diabetes Management
• Obesity Medicine
• Anti-Obesity Medications
• Thyroid Disease in Pregnancy
• Osteoporosis
• Bone Health
• Primary Aldosteronism
• MASLD
• GERD
• Barrett’s Esophagus
• Helicobacter pylori
• Irritable Bowel Syndrome
• Chronic Kidney Disease
• Infectious Diseases
• Antibiotic Stewardship
• Immunizations
• HIV PrEP
• Doxy-PEP
• Geriatric Medicine
• Longevity
• Aging Biomarkers
• Alzheimer’s Disease
• Dementia
• Rheumatology
• Gout
• Crystal Deposition Disease
• Asthma
• COPD
• Headache Disorders
• Stroke
• Pelvic Floor Disorders
• Menopause
• Cancer Screening
• Dermatology
• Depression and Anxiety
• Preoperative Evaluation
• Exercise Medicine
• Cannabinoid Medicine
• Health Equity
• Artificial Intelligence
• ChatGPT in Medicine
• Opioid Use Disorder
• Patient-Centered Care

Cardiovascular Medicine and Risk Reduction

Cardiovascular disease remains a major area of clinical decision-making in internal medicine.

The program examines treatment developments involving heart failure, atrial fibrillation, hypertension, thrombosis, lipid abnormalities, and valvular heart disease.

These educational sessions support clinical understanding of evolving evidence and the appropriate selection of patient-specific cardiovascular treatments.

Diabetes, Obesity and Metabolic Medicine

Advances in diabetes technology and obesity management continue to influence treatment approaches across internal medicine.

The course reviews newer pharmacological therapies, diabetes technologies, nutritional strategies, and other interventions relevant to metabolic disease.

The curriculum also addresses primary aldosteronism, thyroid disease during pregnancy, osteoporosis, and metabolic liver disease.

Gastroenterology, Hepatology and Kidney Disease

Common gastrointestinal, hepatic, and renal disorders frequently require long-term medical management.

The program includes updates involving MASLD, GERD, Barrett’s esophagus, H. pylori infection, irritable bowel syndrome, and chronic kidney disease.

The educational focus emphasizes diagnostic reasoning, current evidence, risk assessment, and individualized treatment decisions.

Infectious Diseases and Preventive Medicine

The infectious disease curriculum addresses important clinical developments affecting outpatient and hospital medicine.

Major topics include antimicrobial stewardship, vaccination, STI prevention, HIV PrEP, Doxy-PEP, and emerging infectious disease issues.

These sessions are relevant to clinicians responsible for antimicrobial prescribing, preventive counseling, and infection management.

Healthy Aging, Longevity and Dementia

Aging and longevity are major educational themes of the 2026 program.

The curriculum examines:

• Healthy Aging
• Longevity Science
• Aging Biomarkers
• Cardiovascular Aging
• Geriatric Research
• Alzheimer’s Disease
• Dementia Management
• Older Adult Care

The presentations help clinicians evaluate emerging longevity research and its practical implications for patients.

Clinical Reasoning and Evidence-Based Care

An important theme throughout the program is translating scientific advances into daily medical practice.

Clinicians are encouraged to integrate:

• Current Research
• Diagnostic Assessment
• Clinical Guidelines
• Individual Patient Characteristics
• Pharmacologic Therapies
• Procedural Treatments
• Medical Technologies
• Nonpharmacologic Interventions
• Shared Decision-Making

The course emphasizes applying clinical evidence while recognizing uncertainty and the need for individualized care.

Artificial Intelligence and Emerging Clinical Technologies

Artificial intelligence is an increasingly prominent area of healthcare innovation.

The curriculum includes a dedicated presentation addressing AI and ChatGPT.

Relevant considerations include potential benefits for clinical workflows, decision support, documentation, education, and information management, alongside the need for accuracy, safety, privacy, and clinician oversight.

Course Leadership

Ole-Petter R. Hamnvik, MB BCh BAO, MMSc

• Associate Professor of Medicine, Harvard Medical School
• Program Director, Endocrinology Fellowship, Brigham and Women’s Hospital
• Education Editor, NEJM Group

Colleen A. Monaghan, MD

• Assistant Professor of Medicine and Pediatrics, Harvard Medical School
• Associate Medical Director, Brigham and Women’s Primary Care
• Associate Program Director, Harvard Medicine-Pediatrics Residency

The course features expert teaching faculty from Harvard Medical School and affiliated medical institutions.

Continuing Medical Education

The original Oakstone educational activity provides up to:

• 33.5 AMA PRA Category 1 Credits™
• 33.5 ABIM Maintenance of Certification Points

Original Release Date: August 31, 2026

Credit Expiration Date: August 30, 2029

The original educational provider requires eligible participants to complete the relevant evaluation and post-test requirements to claim credits.

Important CME Notice

Purchasing separately distributed educational files through MedicalAmboss does not itself provide:

• Official Oakstone CME Credits
• ABIM MOC Points
• Official Certificates
• Oakstone Course Registration
• Publisher Subscription Access
• Official Online Platform Access
• Publisher Accounts
• Publisher-Hosted Benefits

Credit availability and official course participation are governed by Oakstone’s requirements.

Why This Course Is Relevant

The Oakstone The Brigham Innovations and New Practices in Internal Medicine 2026 program provides a broad review of developments affecting contemporary internal medicine.

Its combination of cardiovascular medicine, metabolic disease, pulmonary medicine, infectious diseases, nephrology, gastroenterology, geriatrics, neurology, women’s health, psychiatry, and preventive medicine makes it particularly relevant to practicing internists.

The inclusion of artificial intelligence, longevity, newer obesity treatments, diabetes technology, evolving cardiovascular therapies, and contemporary preventive medicine expands the curriculum beyond conventional internal medicine reviews.

The program supports professional education by connecting emerging evidence with practical clinical reasoning, individualized treatment strategies, and patient-centered medical care.

Official Program Reference and MedicalAmboss Purchase Scope

Official Oakstone Course:

https://oakstone.com/the-brigham-internal-medicine-innovations-and-new-practices/

Original Brigham 2026 Course Syllabus:

https://www.innovationsintmed2026.com/

MedicalAmboss Product:

https://medicalamboss.com/product/oakstone-the-brigham-innovations-and-new-practices-in-internal-medicine-2026/

The official references describe the original educational program, its learning objectives, faculty, release date, and accreditation.

The original program information does not establish the exact inventory of files included with a separately distributed MedicalAmboss product.

MedicalAmboss File Scope: This listing describes the educational subject matter for reference. Provider registration, live attendance, streaming-platform access, CME or other credit, certificates, memberships, apps, accounts, and publisher-hosted extras are not included unless explicitly listed as store files.

Short Description

<div style=”border:2px solid #1677b8;border-radius:10px;padding:12px;background:#f7fbfe;”>

Oakstone The Brigham Innovations and New Practices in Internal Medicine 2026 provides a comprehensive Harvard-affiliated internal medicine update covering emerging treatments, clinical guidelines, diagnostic advances, and evidence-based patient management.

Originally released August 31, 2026, this Oakstone educational video program includes expert presentations addressing cardiology, diabetes, obesity, infectious diseases, gastroenterology, nephrology, pulmonary medicine, geriatrics, rheumatology, neurology, women’s health, clinical reasoning, and artificial intelligence.